News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ABR–Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008



4/11/2008 7:32:51 AM

DENVER, and GOLDEN, Colo., April 11 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today its continued support for the American Association for Cancer Research (AACR) and will exhibit at the annual meeting taking place at the San Diego Convention Center, April 12 - 16, 2008.

"The AACR meeting is a highlight of the year for ABR as we devote a significant portion of our corporate resources to supporting biological research in this critically important area," said Ken Wilczek, President of ABR-Affinity BioReagents. ABR's product portfolio includes over 3,000 quality guaranteed cancer biology antibodies. "Attendance at this meeting affords us the opportunity to enhance our understanding of what today's researchers are focusing on in terms of potential targets and timelines. Each year there are an increasing number of significant developments contributing to extraordinary advances in cancer-related disease research. This is just a great forum in which to interact on a personal level with a cross section of the top life science researchers in the U.S. and around the world. We derive much of our strategic direction from this type of input," finished Mr. Wilczek.

ABR-Affinity BioReagents will be launching 7,500 new products at the meeting across a selection of research areas including: Apoptosis; Cancer Biology; Heat Shock Protein; Ion Transport/Regulation; Neurobiology; Signal Transduction; Transcription Regulation; and Vision.

ABR will be located at booth #820 at next week's meeting in San Diego.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry-research antibodies that are 100% quality guaranteed or your money back-with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.

CONTACT: Leslie Martin of ABR media relations, 1-800-527-4535

Web site: http://www.bioreagents.com/


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES